Preview The new site before launch — its public address will be catsroundtable.com; search engines are told not to index this copy.

Dr. Mason Pimsler Geriatrician, Lincoln Medical Center

Fighting Cancer Through Prevention, Nutrition and Medical Innovation

Aired on 77 WABC 7:25 More with Pimsler

Audio via Spreaker for 77 WABC

In this interview

Dr. Mason Pimsler

Lincoln Medical Center geriatrician Dr. Mason Pimsler tells John Catsimatidis that cancer is becoming an epidemic and that, even with immunotherapy and chemotherapy, it is still not being beaten in 2026. He says the human papillomavirus vaccine is very effective at preventing several cancers, and that there are only three treatment vaccines right now, for metastatic prostate cancer, early-stage bladder cancer and advanced melanoma.

Key takeaways

  • Pimsler said Provenge, made from a patient’s own immune cells, can help metastatic prostate cancer patients live longer.
  • He said BCG is injected into the bladder for non-muscle invasive bladder cancer in the early stage.
  • He said Moderna and Merck are doing these cancer vaccines and are the leaders right now.

In their words

“We have immunotherapy, we have chemotherapies, but we’re still not beating it. We’re still not beating cancer in 2026.”

— Dr. Mason Pimsler, at

“this vaccine, if people would get it, is very effective at preventing cervical cancer, anal, vaginal, penile, and certain head and neck cancers.”

— Dr. Mason Pimsler, at

“If we could do it for COVID... We can do it for cancer. I really believe it.”

— Dr. Mason Pimsler, at

Quotes are word for word from the automated transcript, uncorrected; the summary and takeaways are editorial.

Transcript

Automated transcript · uncorrected

Speaker 1 With us today is Dr. Mason Pimsleur, and he’s with the New York City Health and Hospital Corp. And he’s got a lot of experience and a lot of common sense. And Dr. Pimsleur, what would you like to talk about today?

Speaker 2 So today, I think it’s a good topic that the listeners will.

Speaker 3 Like on this Sunday morning.

Speaker 2 It has to do with cancer because cancer is becoming such an epidemic.

Speaker 3 All types of cancers.

Speaker 2 And that, you know, in 2026 in March, President Trump signed into law and backed a $ 200 million partnership with the National Cancer Institute of Health dedicated exclusively to accelerating therapeutic cancer vaccines. So. This, what we’ll talk about is cancer vaccines, another way to try to beat cancer. We have immunotherapy, we have chemotherapies, but we’re still not beating it. We’re still not beating

cancer in 2026. So we don’t have that many vaccines, but we do have some vaccines. The first thing is we have preventive cancer vaccines that people could get, especially one is called human papillomavirus vaccine that protects against the human papillomavirus, which is a cancer. Like if you looked at actor Michael Douglas, more than likely, this is how

he got his throat cancer through sexual activity. And this vaccine, if people would get it, is very effective at preventing cervical cancer, anal, vaginal, penile, and certain head and neck cancers.

Speaker 3 And this came out probably in about 2007. It’s a preventive vaccine. Preventive. So that’s something very important.

Speaker 1 So you can actually get a vaccine to prevent cancer? Yes. Yes.

Speaker 2 And that’s the human papilloma. And it’s a virus that is sexually, it’s caused sexually, whether through anal, oral, or regular sexual activity. And all, you know, younger children are getting it. Adults can still get it. And it’s very protective because, again, we’re seeing more, which is very interesting, John.

We’re seeing more of an uptick in throat cancers and head and neck cancers. And this can prevent it.

Speaker 3 Well, let me ask you a question.

Speaker 1 And I’ve talked about it with several doctors, including Dr. Milos. If you have a tumor or you have cancer, the thing that feeds tumors and feeds cancers is sugar. So if you have a little bit of cancer, you should cut out sugar down to zero.

Speaker 2 I agree 100%. I have discussed this. And, you know, when you get diagnosed with cancer, there’s a test that they use to see how the cancer is doing. It’s called the PET scan, positron emissions test. And you know what that test is based on? Sugar uptake in the cancer cells. They give you an injection and it’s based

on sugar uptake. And so I do believe in that. I do believe in that a hundred percent eliminate sugar.

Speaker 3 If you have cancer, even if you don’t.

Speaker 1 Have the cancer, a lot of people probably haven’t talked about it, but starving the cancer could help a little bit.

Speaker 3 Agreed. Agreed. Especially with cancer. We’re in a jungle.

Speaker 2 Anything goes because we just, you know, don’t have the most therapeutic or most, the greatest treatments for a lot of cancers. Some we do, but for majority, we don’t still in 2026. Cancer is still cancer. But that was very, that’s a great point with the sugar. Because if people look it up, your listeners look up the PET scan,

which is used to follow cancers. What they’re doing is injecting like a sugar molecule and see how the tumors uptake it.

Speaker 3 So I believe in that wholeheartedly.

Speaker 1 Anything else? What else would you like to tell people? What else? What other tips can you give them?

Speaker 3 So the other thing, wait, I’m sorry, John, what other tests? Tips. Tips.

Speaker 2 Well, I wanted to say the prevention I was giving you was the vaccine, but there are some treatment vaccines out there now.

Speaker 3 One is called Cipolosello, or I’m going to use.

Speaker 2 The brand name of it, Provenge for prostate cancer. And you had an employee that had metastatic, your host, Bernie McGurk. And there is an approved cancer vaccine for metastatic prostate cancer called Prevenge. And it has shown to extend life in one of the latest studies by 30 months. What it is, it’s personalized. they harness a patient’s own immune cells.

So say for instance, patient X had prostate cancer and it was metastatic, meaning what does metastatic mean? Meaning that it’s outside of the prostate. It goes to the bones, the lymph nodes, other places. So they harvest one’s own immune cells and immune cells are our own natural cells that fight against infections and cancer. And then they make

this in the lab, they make this vaccine and it can help people with metastatic prostate cancer live longer.

Speaker 3 So that’s a good one, because.

Speaker 2 There’s only three right now, only three of the cancer vaccines right now. And thankfully, Trump put in two hundred million dollars in March of twenty twenty six.

Speaker 3 We hope we get more. But there’s another one for bladder cancer.

Speaker 2 BCG, if you have bladder cancer, is originally made for cancer. Tuberculosis. Now what they do is they inject this vaccine into the bladder, non-muscle invasive bladder cancer that’s in the early stage.

Speaker 3 And it could really, really help.

Speaker 2 And there’s another cancer vaccine for melanoma. You know, we like to get our sun tans.

Speaker 3 And being from Greece, the.

Speaker 2 Beautiful country, in the sun, in the sunshine, you know, if you don’t wear the proper sun protection, hats, stuff like that, you’re at high risk to get skin cancers. And if you get advanced melanoma, there’s a vaccine called Limgic.

Speaker 3 For that as well. So we do have three vaccines out there. We need more. We need more.

Speaker 2 If we could do it for COVID... We can do it for cancer. I really believe it. And it’s Moderna and Merck that are doing these vaccines, actually. They’re the leaders right now.

Speaker 1 Well, Dr. Mason Pimsleur, thank you so much for coming on and thank you for the advice. And I hope all our listeners live at least 10 years longer.

Speaker 3 Oh, absolutely. And like we say, to 100, if at least. Thank you so much. Thank you, John, so much.

Report an error
Same Sunday

Sunday, November 1, 2026

22 interviews · 127 minutes The whole Sunday
More with this guest

Dr. Mason Pimsler

Now playing:
Dr. Mason Pimsler Fighting Cancer Through Prevention, Nutrition and Medical Innovation